Lisa-Mari Mörk1, Stephen C Strom2, Agneta Mode3, Ewa C S Ellis1. 1. Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden. 2. Department of Laboratory Medicine, Division of Pathology, Karolinska Institute, Sweden. 3. Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
Abstract
BACKGROUND: Primary human hepatocytes offer the best human in vitro model for studies on human liver cell metabolism. Investigators use a variety of different media supplements and matrix biocoatings and the type of culture system used may influence the outcome. OBJECTIVES: To optimize in vitro conditions for primary human hepatocytes with regard to bile acid synthesis. METHODS: Human hepatocytes were isolated and cultured on collagen type I or EHS matrigel in cell media with or without dexamethasone. The glucocorticoid receptor (GR) antagonist RU486 was used to elucidate the involvement of GR. RESULTS: Hepatocytes cultured on EHS matrigel produced more bile acids and expressed higher levels of cholesterol 7α-hydroxylase (CYP7A1) than cells cultured on rat tail collagen. Supplementation with dexamethasone increased the formation of cholic acid (CA) and decreased chenodeoxycholic acid formation. In line with these results, the mRNA expression of sterol 12α-hydroxylase (CYP8B1) increased following dexamethasone treatment. Surprisingly, the mRNA expression of CYP7A1 and CYP27A1 was not increased to the same extent. By using the GR antagonist RU486, we concluded that CYP8B1 induction is mediated via a GR-independent pathway. An altered expression of retinoid-related orphan receptor (ROR) α and ROR α target gene Glucose-6-phosphatase (G6Pase) suggests that ROR α signaling may regulate CYP8B1 expression. CONCLUSION: Primary human hepatocytes have an increased bile acid synthesis rate when cultured on matrigel as compared to collagen. Exposure to glucocorticoid hormones stimulates the expression of CYP8B1, leading to an increased formation of CA and alteration of the bile acid composition. The effect is most likely mediated through a GR-independent pathway, possibly through ROR α.
BACKGROUND: Primary human hepatocytes offer the best human in vitro model for studies on human liver cell metabolism. Investigators use a variety of different media supplements and matrix biocoatings and the type of culture system used may influence the outcome. OBJECTIVES: To optimize in vitro conditions for primary human hepatocytes with regard to bile acid synthesis. METHODS:Human hepatocytes were isolated and cultured on collagen type I or EHS matrigel in cell media with or without dexamethasone. The glucocorticoid receptor (GR) antagonist RU486 was used to elucidate the involvement of GR. RESULTS: Hepatocytes cultured on EHS matrigel produced more bile acids and expressed higher levels of cholesterol 7α-hydroxylase (CYP7A1) than cells cultured on rat tail collagen. Supplementation with dexamethasone increased the formation of cholic acid (CA) and decreased chenodeoxycholic acid formation. In line with these results, the mRNA expression of sterol 12α-hydroxylase (CYP8B1) increased following dexamethasone treatment. Surprisingly, the mRNA expression of CYP7A1 and CYP27A1 was not increased to the same extent. By using the GR antagonist RU486, we concluded that CYP8B1 induction is mediated via a GR-independent pathway. An altered expression of retinoid-related orphan receptor (ROR) α and ROR α target gene Glucose-6-phosphatase (G6Pase) suggests that ROR α signaling may regulate CYP8B1 expression. CONCLUSION: Primary human hepatocytes have an increased bile acid synthesis rate when cultured on matrigel as compared to collagen. Exposure to glucocorticoid hormones stimulates the expression of CYP8B1, leading to an increased formation of CA and alteration of the bile acid composition. The effect is most likely mediated through a GR-independent pathway, possibly through ROR α.
Entities:
Keywords:
BSEP, bile salt export pump; CA, cholic acid; CDCA, chenodeoxycholic acid; CYP27A1, sterol 27α-hydroxylase; CYP7A1, cholesterol 7α-hydroxylase; CYP8B1, sterol 12α-hydroxylase; FXR, farnesoid X receptor; G6Pase, glucose-6-phosphatase; GR, glucocorticoid receptor; NTCP, Na+-taurocholate cotransporting polypeptide; PXR, pregnane X receptor; ROR, retinoid-related orphan receptor; chenodeoxycholic acid; cholic acid; dexamethasone; matrigel; primary hepatocytes
Authors: E Ellis; B Goodwin; A Abrahamsson; C Liddle; A Mode; M Rudling; I Bjorkhem; C Einarsson Journal: Hepatology Date: 1998-02 Impact factor: 17.425
Authors: J M Silva; P E Morin; S H Day; B P Kennedy; P Payette; T Rushmore; J A Yergey; D A Nicoll-Griffith Journal: Drug Metab Dispos Date: 1998-05 Impact factor: 3.922
Authors: B Goodwin; S A Jones; R R Price; M A Watson; D D McKee; L B Moore; C Galardi; J G Wilson; M C Lewis; M E Roth; P R Maloney; T M Willson; S A Kliewer Journal: Mol Cell Date: 2000-09 Impact factor: 17.970
Authors: Atul R Chopra; Jean-Francois Louet; Pradip Saha; Jie An; Franco Demayo; Jianming Xu; Brian York; Saul Karpen; Milton Finegold; David Moore; Lawrence Chan; Christopher B Newgard; Bert W O'Malley Journal: Science Date: 2008-11-28 Impact factor: 47.728
Authors: Ujjal Sarkar; Kodihalli C Ravindra; Emma Large; Carissa L Young; Dinelia Rivera-Burgos; Jiajie Yu; Murat Cirit; David J Hughes; John S Wishnok; Douglas A Lauffenburger; Linda G Griffith; Steven R Tannenbaum Journal: Drug Metab Dispos Date: 2017-04-27 Impact factor: 3.922
Authors: Nikolaos Nikolaou; Anastasia Arvaniti; Nathan Appanna; Anna Sharp; Beverly A Hughes; Dena Digweed; Martin J Whitaker; Richard Ross; Wiebke Arlt; Trevor M Penning; Karen Morris; Sherly George; Brian G Keevil; Leanne Hodson; Laura L Gathercole; Jeremy W Tomlinson Journal: J Endocrinol Date: 2020-05 Impact factor: 4.286
Authors: Chitra Saran; Dong Fu; Henry Ho; Abigail Klein; John K Fallon; Paavo Honkakoski; Kim L R Brouwer Journal: Sci Rep Date: 2022-08-22 Impact factor: 4.996
Authors: Daniela Gabbia; Luisa Pozzo; Giorgia Zigiotto; Marco Roverso; Diana Sacchi; Arianna Dalla Pozza; Maria Carrara; Sara Bogialli; Annarosa Floreani; Maria Guido; Sara De Martin Journal: PLoS One Date: 2018-09-25 Impact factor: 3.240